CoChat

Aerobic, resistance, or combined exercise training and cardiovascular risk profile in overweight or obese adults: the CardioRACE trial

Open access
Lee, Duck-chul, Brellenthin, Angelique G, Lanningham-Foster, Lorraine M, Kohut, Marian L, Li, Yehua · 2024 · European Heart Journal

The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index; 25 of the 37 sources its claims cite were checked for support.

Abstract

Background and Aims: To determine the comparative efficacy of resistance, aerobic, and combined resistance plus aerobic exercise on cardiovascular disease (CVD) risk profile. Methods: This randomized controlled trial enrolled 406 adults aged 35–70 years with overweight or obesity and elevated blood pressure. Participants were randomly assigned to resistance (n = 102), aerobic (n = 101), combined resistance plus aerobic exercise (n = 101), or no-exercise control (n = 102). All exercise participants were prescribed 1 h of time-matched supervised exercise (the combination group with 30 min of each resistance and aerobic exercise) three times per week for 1 year. The primary outcome was the change from baseline to 1 year in the standardized composite Z-score of four well-established CVD risk factors: systolic blood pressure, low-density lipoprotein (LDL) cholesterol, fasting glucose, and per cent body fat. Results: Among 406 participants (53% women), 381 (94%) completed 1-year follow-up. Compared with the control group, the composite Z-score decreased at 1 year, which indicates improved CVD risk profile, in the aerobic {mean difference, −0.15 [95% confidence interval (CI): −0.27 to −0.04]; P = .01} and combination [mean difference, −0.16 (95% CI: −0.27 to −0.04); P = .009] groups, but not in the resistance [mean difference, −0.02 (95% CI: −0.14 to 0.09); P = .69] group. Both aerobic and combination groups had greater reductions in the composite Z-score compared with the resistance group (both P = .03), and there was no difference between the aerobic and combination groups (P = .96). Regarding the four individual CVD risk factors, only per cent body fat decreased in all three exercise groups at 1 year, but systolic blood pressure, LDL cholesterol, and fasting glucose did not decrease in any exercise groups, compared with the control group. Conclusions: In adults with overweight or obesity, aerobic exercise alone or combined resistance plus aerobic exercise, but not resistance exercise alone, improved composite CVD risk profile compared with the control.

Overview

CoChat Summary

TL;DR

In the CardioRACE randomized trial of 406 adults with overweight or obesity and elevated blood pressure, aerobic exercise alone or combined resistance plus aerobic exercise improved a composite CVD risk Z-score over 1 year compared with no-exercise control, while resistance exercise alone did not. The combined group achieved similar composite risk improvement to aerobic exercise alone despite doing half the aerobic dose.

Key findings

  • The composite CVD risk Z-score decreased versus control in the aerobic group {mean difference, −0.15 [95% CI: −0.27 to −0.04]; P = .01} and combination group {−0.16 [−0.27 to −0.04]; P = .009}, but not the resistance group {−0.02 [−0.14 to 0.09]; P = .69}. Aerobic and combination groups had greater reductions than resistance (both P = .03), with no difference between aerobic and combination (P = .96).
  • Among the four individual components, only per cent body fat decreased in all exercise groups versus control: resistance −0.9% (−1.4 to −0.3; P = .001), aerobic −1.0% (−1.5 to −0.4; P < .001), and combination −1.0% (−1.6 to −0.5; P < .001). Systolic blood pressure, LDL cholesterol, and fasting glucose did not decrease in any exercise group versus control.
  • Secondary outcomes included increased HDL cholesterol in all exercise groups versus control (resistance 1.9 mg/dL, P = .04; aerobic 2.0 mg/dL, P = .03; combination 2.3 mg/dL, P = .01), decreased waist circumference in aerobic (−1.9 cm, P = .03) and combination (−2.2 cm, P = .01), increased lean body mass in resistance (1.2 kg, P < .001), and increased VO2peak in resistance (1.3 mL/kg/min, P = .048), aerobic (3.5 mL/kg/min, P < .001), and combination (2.7 mL/kg/min, P < .001).
  • Estimated 10-year Framingham CHD risk decreased in the combination group by −1.1% (from 7.2% to 6.1%; P < .001) and was larger than control (P = .03), with no significant changes in aerobic (−0.5%; P = .10) or resistance (0.1%; P = .76) groups.

Methods

  • Randomized controlled trial conducted July 2017–March 2020 at Iowa State University; 406 adults aged 35–70 years, BMI 25–40 kg/m², elevated blood pressure 120–139/80–89 mmHg without antihypertensive medications, inactive, and non-smokers were randomized to resistance (n = 102), aerobic (n = 101), combined resistance plus aerobic (n = 101), or no-exercise control (n = 102); 381 (94%) completed 1-year follow-up.
  • Exercise groups were prescribed time-matched supervised exercise 3 times/week for 1 year: 60 min/session total, with 50 min resistance, 50 min aerobic, or 25 min each in the combination group; control received no exercise during year 1 but was offered delayed exercise. All participants received DASH diet education and counseling.
  • The primary outcome was change from baseline to 1 year in a standardized composite Z-score of systolic blood pressure, LDL cholesterol, fasting glucose, and per cent body fat. Analyses used linear mixed effects models with repeated measures, intention-to-treat, adjusted for age, sex, and baseline outcome value, with Bonferroni correction for three control comparisons.

Limitations

  • The paper states that most participants were white and well educated, limiting generalizability; it was a single-centre supervised efficacy trial, so real-world effects may differ; whether improved composite risk lowers hard CVD events is unknown; exercise groups were matched by time rather than energy expenditure; participants were not blinded; baseline activity and diet were self-reported; and the pedometer did not capture all activity.
  • The paper also states that aerobic attendance at 1 year was lower (77%) than resistance (84%, P = .04) or combination (85%, P = .02), and that per-protocol results suggested aerobic exercise might be more efficacious at a sufficient dose while combined exercise may be more effective long term due to adherence.
  • Evident from the text: changes in individual risk factors were modest, which the authors attribute partly to relatively healthy participants with mildly elevated baseline risk factors and limited room for improvement; the control group also had nonsignificantly more daily steps and muscle-strengthening activity, which the authors note could plausibly have influenced results.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehad827

Cites

45 of 46 references verified0 citation errors · 1 not checkable

Statistics

Nothing to recompute.

Figures

Structured Graphical Abstract Effects of 1-year resistance, aerobic, or combined exercise training on cardiovascular disease (CVD) risk profile: the CardioRACE trial. Aerobic exercise alone or combined aerobic plus resistance exercise, but not resistance exercise alone, improved CVD risk profile (composite Z-score) compared with no-exercise control (Z-score values below 0 indicate favourable changes in CVD risk factors). BMI, body mass index; CI, confidence interval; CVD, cardiovascular disease; DBP, diastolic blood pressure; SBP, systolic blood pressure.
Structured Graphical Abstract Effects of 1-year resistance, aerobic, or combined exercise training on cardiovascular disease (CVD) risk profile: the CardioRACE trial. Aerobic exercise alone or combined aerobic plus resistance exercise, but not resistance exercise alone, improved CVD risk profile (composite Z-score) compared with no-exercise control (Z-score values below 0 indicate favourable changes in CVD risk factors). BMI, body mass index; CI, confidence interval; CVD, cardiovascular disease; DBP, diastolic blood pressure; SBP, systolic blood pressure.CC BY · PubMed Central
Figure 1 Participant screening, randomization, and follow-up. All these 406 participants were analyzed in the intention-to-treat analysis
Figure 1 Participant screening, randomization, and follow-up. All these 406 participants were analyzed in the intention-to-treat analysisCC BY · PubMed Central
Figure 2 Changes in the cardiovascular disease risk factors from baseline to 1 year. Results are from the linear mixed effects models with repeated measures in the intention-to-treat analyses including all 406 randomized participants. The figure shows mean changes in the standardized Z-scores of the composite cardiovascular disease risk factors by sex and age groups (A) and mean changes in the standardized Z-scores of the individual and composite cardiovascular disease risk factors (B). P-values for interaction by sex were .22, .70, .09, and .78 in the control, resistance, aerobic, and combination groups, respectively. P-values for interaction by the age groups were .14, .79, .67, and .40 in the control, resistance, aerobic, and combination groups, respectively. Z-score values below 0 indicate favourable changes in cardiovascular disease risk factors. Whiskers indicate 95% confidence intervals. CVD, cardiovascular disease; LDL, CI, confidence interval
Figure 2 Changes in the cardiovascular disease risk factors from baseline to 1 year. Results are from the linear mixed effects models with repeated measures in the intention-to-treat analyses including all 406 randomized participants. The figure shows mean changes in the standardized Z-scores of the composite cardiovascular disease risk factors by sex and age groups (A) and mean changes in the standardized Z-scores of the individual and composite cardiovascular disease risk factors (B). P-values for interaction by sex were .22, .70, .09, and .78 in the control, resistance, aerobic, and combination groups, respectively. P-values for interaction by the age groups were .14, .79, .67, and .40 in the control, resistance, aerobic, and combination groups, respectively. Z-score values below 0 indicate favourable changes in cardiovascular disease risk factors. Whiskers indicate 95% confidence intervals. CVD, cardiovascular disease; LDL, CI, confidence intervalCC BY · PubMed Central
Figure 3 Mean per cent changes in cardiorespiratory fitness and muscular strength from baseline to 6 and 12 months. Results are from the linear mixed effects models with repeated measures in the intention-to-treat analyses including all 406 randomized participants. The figure shows cardiorespiratory fitness (A) measured in the peak oxygen consumption, one-repetition maximum chest press (B), and one-repetition maximum leg press (C) measured at baseline, 6 months, and 12 months. Error bars represent 95% confidence intervals. 1RM, one-repetition maximum (the maximum weight a participant can lift in one attempt); VO2peak, peak oxygen consumption
Figure 3 Mean per cent changes in cardiorespiratory fitness and muscular strength from baseline to 6 and 12 months. Results are from the linear mixed effects models with repeated measures in the intention-to-treat analyses including all 406 randomized participants. The figure shows cardiorespiratory fitness (A) measured in the peak oxygen consumption, one-repetition maximum chest press (B), and one-repetition maximum leg press (C) measured at baseline, 6 months, and 12 months. Error bars represent 95% confidence intervals. 1RM, one-repetition maximum (the maximum weight a participant can lift in one attempt); VO2peak, peak oxygen consumptionCC BY · PubMed Central
Figure 4 Mean changes in lifestyle physical activity and diet during 12 months. The figure shows the mean changes in daily steps (A), muscle-strengthening activity (B), total daily energy intake (C), percentage of calories from protein (D), percentage of calories from total fat (E), and Dietary Approaches to Stop Hypertension diet score (F). Average numbers of participants across groups from Month 1 to Month 12 were 99, 95, 93, 92, 89, 87, 84, 80, 78, 76, 74, and 73, respectively, for physical activity (daily steps and muscle-strengthening activity) and 95, 88, 88, 83, 81, 79, 76, 74, 72, 68, 66, and 46, respectively, for diet (total daily energy intake, percentage of calories from protein, percentage of calories from total fat, and Dietary Approaches to Stop Hypertension diet score). P-values for group-by-time interactions are as follows: P = .37 for daily steps, P = .97 for muscle-strengthening activity, P = .67 for total daily energy intake, P = .42 for percentage of calories from protein, P = .43 for percentage of calories from total fat, and P = .53 for Dietary Approaches to Stop Hypertension diet score. DASH, Dietary Approaches to Stop Hypertension [ranges from 0 (low DASH accordance) to 9 (high DASH accordance)].
Figure 4 Mean changes in lifestyle physical activity and diet during 12 months. The figure shows the mean changes in daily steps (A), muscle-strengthening activity (B), total daily energy intake (C), percentage of calories from protein (D), percentage of calories from total fat (E), and Dietary Approaches to Stop Hypertension diet score (F). Average numbers of participants across groups from Month 1 to Month 12 were 99, 95, 93, 92, 89, 87, 84, 80, 78, 76, 74, and 73, respectively, for physical activity (daily steps and muscle-strengthening activity) and 95, 88, 88, 83, 81, 79, 76, 74, 72, 68, 66, and 46, respectively, for diet (total daily energy intake, percentage of calories from protein, percentage of calories from total fat, and Dietary Approaches to Stop Hypertension diet score). P-values for group-by-time interactions are as follows: P = .37 for daily steps, P = .97 for muscle-strengthening activity, P = .67 for total daily energy intake, P = .42 for percentage of calories from protein, P = .43 for percentage of calories from total fat, and P = .53 for Dietary Approaches to Stop Hypertension diet score. DASH, Dietary Approaches to Stop Hypertension [ranges from 0 (low DASH accordance) to 9 (high DASH accordance)].CC BY · PubMed Central

Verification

Claims the paper makes

13 Valid · 1 Not valid · 5 Not checked · 118 Own results and interpretations

76 more claims

Create a free account to see all 137 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 37
  • Probably not a substantial claim. 29
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 46 references

Research works printed but not linked: 1

  1. World Health Organization, 2020, WHO Guidelines on Physical Activity and Sedentary Behaviour

Cited by

See all 108

Metadata

Authors
Lee, D.-C., Brellenthin, A. G., Lanningham-Foster, L. M., Kohut, M. L., & Li, Y.
Affiliations
  • Iowa State University (US)
  • Department of Kinesiology, Iowa State University , 534 Wallace Road, Ames, IA 50011 , USA
  • University of California, Riverside (US)
Corresponding author
Lee, Duck-chul
Venue
European Heart Journal
Published
2024-01-17
Volume
45
Issue
13
Pages
1127-1142
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W4390989018
Cited by
108
References
44
Citations by year
2026: 46 · 2025: 39 · 2024: 23
FWCI
17.15
Type
journal article
Language
en
Open access
Locations
  • European Heart Journal (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Heart, Lung, and Blood Institute
  • US National Institutes of Health (R01HL133069)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
aerobic exercise, resistance training, concurrent training, cardiovascular risk profile, overweight, obesity, elevated blood pressure, systolic blood pressure, LDL cholesterol, fasting blood glucose, body fat percentage, cardiovascular risk factors, supervised exercise
MeSH terms
Heart Disease Risk Factors, Adult, Cardiovascular Diseases, Female, Glucose, Humans, Cholesterol, LDL, Male, Obesity, Risk Factors, Exercise, Overweight

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aerobic, resistance, or combined exercise training and cardiovascular risk profile in overweight or obese adults: the CardioRACE trial. https://app.cochat.ai/papers/10.1093/eurheartj/ehad827
The paper
Lee, D.-C., Brellenthin, A. G., Lanningham-Foster, L. M., Kohut, M. L., & Li, Y. (2024). Aerobic, resistance, or combined exercise training and cardiovascular risk profile in overweight or obese adults: the CardioRACE trial. European Heart Journal. https://doi.org/10.1093/eurheartj/ehad827

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.